DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Gettinger SN, Horn L, Gandhi L et al.
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol 2015;
33: 2004-2012
We do not assume any responsibility for the contents of the web pages of other providers.